nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—ORM1—Tacrolimus—atopic dermatitis	0.702	1	CbGbCtD
Penbutolol—Throat sore—Pimecrolimus—atopic dermatitis	0.00859	0.0306	CcSEcCtD
Penbutolol—Oropharyngeal discomfort—Pimecrolimus—atopic dermatitis	0.00852	0.0303	CcSEcCtD
Penbutolol—Thrombocytopenic purpura—Tacrolimus—atopic dermatitis	0.00719	0.0256	CcSEcCtD
Penbutolol—Oropharyngeal pain—Pimecrolimus—atopic dermatitis	0.00681	0.0243	CcSEcCtD
Penbutolol—Respiratory distress—Tacrolimus—atopic dermatitis	0.00531	0.0189	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Desonide—atopic dermatitis	0.00511	0.0182	CcSEcCtD
Penbutolol—Sweating—Desonide—atopic dermatitis	0.0047	0.0168	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Pimecrolimus—atopic dermatitis	0.00361	0.0129	CcSEcCtD
Penbutolol—Cough—Desonide—atopic dermatitis	0.00335	0.0119	CcSEcCtD
Penbutolol—Agranulocytosis—Diphenhydramine—atopic dermatitis	0.00334	0.0119	CcSEcCtD
Penbutolol—Agranulocytosis—Dimenhydrinate—atopic dermatitis	0.00334	0.0119	CcSEcCtD
Penbutolol—Hyperhidrosis—Desonide—atopic dermatitis	0.00302	0.0108	CcSEcCtD
Penbutolol—Depression—Loratadine—atopic dermatitis	0.00275	0.0098	CcSEcCtD
Penbutolol—Throat sore—Triamcinolone—atopic dermatitis	0.00275	0.00978	CcSEcCtD
Penbutolol—Disorientation—Tacrolimus—atopic dermatitis	0.00273	0.00974	CcSEcCtD
Penbutolol—Oropharyngeal discomfort—Triamcinolone—atopic dermatitis	0.00272	0.00969	CcSEcCtD
Penbutolol—Pain—Desonide—atopic dermatitis	0.00268	0.00953	CcSEcCtD
Penbutolol—Amnesia—Tacrolimus—atopic dermatitis	0.0026	0.00927	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Fluocinolone Acetonide—atopic dermatitis	0.00259	0.00921	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Mometasone—atopic dermatitis	0.00247	0.00879	CcSEcCtD
Penbutolol—Affect lability—Tacrolimus—atopic dermatitis	0.00241	0.00858	CcSEcCtD
Penbutolol—Cough—Pimecrolimus—atopic dermatitis	0.00236	0.00842	CcSEcCtD
Penbutolol—Rash erythematous—Betamethasone—atopic dermatitis	0.00235	0.00835	CcSEcCtD
Penbutolol—Rash erythematous—Dexamethasone—atopic dermatitis	0.00235	0.00835	CcSEcCtD
Penbutolol—Mood swings—Tacrolimus—atopic dermatitis	0.00232	0.00825	CcSEcCtD
Penbutolol—Hyperhidrosis—Diphenhydramine—atopic dermatitis	0.00221	0.00787	CcSEcCtD
Penbutolol—Hyperhidrosis—Dimenhydrinate—atopic dermatitis	0.00221	0.00787	CcSEcCtD
Penbutolol—Alopecia—Loratadine—atopic dermatitis	0.00219	0.0078	CcSEcCtD
Penbutolol—Oropharyngeal pain—Triamcinolone—atopic dermatitis	0.00218	0.00775	CcSEcCtD
Penbutolol—Pain—Fluocinonide—atopic dermatitis	0.00217	0.00772	CcSEcCtD
Penbutolol—Insomnia—Dimenhydrinate—atopic dermatitis	0.00207	0.00736	CcSEcCtD
Penbutolol—Insomnia—Diphenhydramine—atopic dermatitis	0.00207	0.00736	CcSEcCtD
Penbutolol—Dyspepsia—Dimenhydrinate—atopic dermatitis	0.00201	0.00717	CcSEcCtD
Penbutolol—Dyspepsia—Diphenhydramine—atopic dermatitis	0.00201	0.00717	CcSEcCtD
Penbutolol—Fatigue—Dimenhydrinate—atopic dermatitis	0.00197	0.00702	CcSEcCtD
Penbutolol—Fatigue—Diphenhydramine—atopic dermatitis	0.00197	0.00702	CcSEcCtD
Penbutolol—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00197	0.00702	CcSEcCtD
Penbutolol—Alopecia—Fluocinolone Acetonide—atopic dermatitis	0.00197	0.00701	CcSEcCtD
Penbutolol—Headache—Desonide—atopic dermatitis	0.00196	0.00698	CcSEcCtD
Penbutolol—Pain—Pimecrolimus—atopic dermatitis	0.00189	0.00673	CcSEcCtD
Penbutolol—Cough—Loratadine—atopic dermatitis	0.00188	0.0067	CcSEcCtD
Penbutolol—Depression—Tacrolimus—atopic dermatitis	0.00188	0.0067	CcSEcCtD
Penbutolol—Sweating—Tacrolimus—atopic dermatitis	0.00181	0.00644	CcSEcCtD
Penbutolol—Agranulocytosis—Tacrolimus—atopic dermatitis	0.00176	0.00627	CcSEcCtD
Penbutolol—Body temperature increased—Pimecrolimus—atopic dermatitis	0.00175	0.00622	CcSEcCtD
Penbutolol—Bradycardia—Tacrolimus—atopic dermatitis	0.00172	0.00614	CcSEcCtD
Penbutolol—Cough—Fluocinolone Acetonide—atopic dermatitis	0.00169	0.00603	CcSEcCtD
Penbutolol—Dizziness—Fluocinonide—atopic dermatitis	0.00168	0.00597	CcSEcCtD
Penbutolol—Asthenia—Diphenhydramine—atopic dermatitis	0.00164	0.00584	CcSEcCtD
Penbutolol—Asthenia—Dimenhydrinate—atopic dermatitis	0.00164	0.00584	CcSEcCtD
Penbutolol—Cough—Mometasone—atopic dermatitis	0.00162	0.00575	CcSEcCtD
Penbutolol—Insomnia—Loratadine—atopic dermatitis	0.00159	0.00567	CcSEcCtD
Penbutolol—Headache—Fluocinonide—atopic dermatitis	0.00159	0.00566	CcSEcCtD
Penbutolol—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00156	0.00557	CcSEcCtD
Penbutolol—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00156	0.00557	CcSEcCtD
Penbutolol—Dyspepsia—Loratadine—atopic dermatitis	0.00155	0.00552	CcSEcCtD
Penbutolol—Affect lability—Prednisolone—atopic dermatitis	0.00154	0.00548	CcSEcCtD
Penbutolol—Amnesia—Methylprednisolone—atopic dermatitis	0.00153	0.00544	CcSEcCtD
Penbutolol—Fatigue—Loratadine—atopic dermatitis	0.00152	0.00541	CcSEcCtD
Penbutolol—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00151	0.00539	CcSEcCtD
Penbutolol—Dizziness—Dimenhydrinate—atopic dermatitis	0.00151	0.00538	CcSEcCtD
Penbutolol—Dizziness—Diphenhydramine—atopic dermatitis	0.00151	0.00538	CcSEcCtD
Penbutolol—Pain—Loratadine—atopic dermatitis	0.00151	0.00536	CcSEcCtD
Penbutolol—Affect lability—Hydrocortisone—atopic dermatitis	0.0015	0.00535	CcSEcCtD
Penbutolol—Alopecia—Tacrolimus—atopic dermatitis	0.0015	0.00533	CcSEcCtD
Penbutolol—Mood swings—Prednisolone—atopic dermatitis	0.00148	0.00527	CcSEcCtD
Penbutolol—Mood swings—Hydrocortisone—atopic dermatitis	0.00145	0.00515	CcSEcCtD
Penbutolol—Headache—Diphenhydramine—atopic dermatitis	0.00143	0.0051	CcSEcCtD
Penbutolol—Headache—Dimenhydrinate—atopic dermatitis	0.00143	0.0051	CcSEcCtD
Penbutolol—Affect lability—Triamcinolone—atopic dermatitis	0.00141	0.00504	CcSEcCtD
Penbutolol—Affect lability—Methylprednisolone—atopic dermatitis	0.00141	0.00503	CcSEcCtD
Penbutolol—Body temperature increased—Loratadine—atopic dermatitis	0.00139	0.00496	CcSEcCtD
Penbutolol—Headache—Pimecrolimus—atopic dermatitis	0.00138	0.00493	CcSEcCtD
Penbutolol—Mood swings—Triamcinolone—atopic dermatitis	0.00136	0.00485	CcSEcCtD
Penbutolol—Mood swings—Methylprednisolone—atopic dermatitis	0.00136	0.00484	CcSEcCtD
Penbutolol—Nausea—Dimenhydrinate—atopic dermatitis	0.00136	0.00484	CcSEcCtD
Penbutolol—Nausea—Diphenhydramine—atopic dermatitis	0.00136	0.00484	CcSEcCtD
Penbutolol—Pain—Fluocinolone Acetonide—atopic dermatitis	0.00135	0.00482	CcSEcCtD
Penbutolol—Dyspnoea—Mometasone—atopic dermatitis	0.00135	0.0048	CcSEcCtD
Penbutolol—Dyspepsia—Mometasone—atopic dermatitis	0.00133	0.00474	CcSEcCtD
Penbutolol—Nausea—Pimecrolimus—atopic dermatitis	0.00131	0.00468	CcSEcCtD
Penbutolol—Fatigue—Mometasone—atopic dermatitis	0.0013	0.00464	CcSEcCtD
Penbutolol—Pain—Mometasone—atopic dermatitis	0.00129	0.0046	CcSEcCtD
Penbutolol—Cough—Tacrolimus—atopic dermatitis	0.00129	0.00458	CcSEcCtD
Penbutolol—Affect lability—Dexamethasone—atopic dermatitis	0.00128	0.00457	CcSEcCtD
Penbutolol—Affect lability—Betamethasone—atopic dermatitis	0.00128	0.00457	CcSEcCtD
Penbutolol—Asthenia—Loratadine—atopic dermatitis	0.00126	0.0045	CcSEcCtD
Penbutolol—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.00125	0.00445	CcSEcCtD
Penbutolol—Mood swings—Dexamethasone—atopic dermatitis	0.00124	0.0044	CcSEcCtD
Penbutolol—Mood swings—Betamethasone—atopic dermatitis	0.00124	0.0044	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.00123	0.00437	CcSEcCtD
Penbutolol—Amnesia—Prednisone—atopic dermatitis	0.00121	0.0043	CcSEcCtD
Penbutolol—Diarrhoea—Loratadine—atopic dermatitis	0.0012	0.00429	CcSEcCtD
Penbutolol—Body temperature increased—Mometasone—atopic dermatitis	0.00119	0.00425	CcSEcCtD
Penbutolol—Dizziness—Loratadine—atopic dermatitis	0.00116	0.00415	CcSEcCtD
Penbutolol—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.00116	0.00414	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.00115	0.00411	CcSEcCtD
Penbutolol—Affect lability—Prednisone—atopic dermatitis	0.00112	0.00398	CcSEcCtD
Penbutolol—Headache—Loratadine—atopic dermatitis	0.0011	0.00393	CcSEcCtD
Penbutolol—Bradycardia—Prednisolone—atopic dermatitis	0.0011	0.00392	CcSEcCtD
Penbutolol—Insomnia—Tacrolimus—atopic dermatitis	0.00109	0.00387	CcSEcCtD
Penbutolol—Asthenia—Mometasone—atopic dermatitis	0.00108	0.00386	CcSEcCtD
Penbutolol—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00108	0.00386	CcSEcCtD
Penbutolol—Mood swings—Prednisone—atopic dermatitis	0.00108	0.00383	CcSEcCtD
Penbutolol—Bradycardia—Hydrocortisone—atopic dermatitis	0.00107	0.00383	CcSEcCtD
Penbutolol—Dyspnoea—Tacrolimus—atopic dermatitis	0.00107	0.00382	CcSEcCtD
Penbutolol—Sweating—Methylprednisolone—atopic dermatitis	0.00106	0.00377	CcSEcCtD
Penbutolol—Dyspepsia—Tacrolimus—atopic dermatitis	0.00106	0.00377	CcSEcCtD
Penbutolol—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00105	0.00373	CcSEcCtD
Penbutolol—Nausea—Loratadine—atopic dermatitis	0.00105	0.00372	CcSEcCtD
Penbutolol—Fatigue—Tacrolimus—atopic dermatitis	0.00104	0.00369	CcSEcCtD
Penbutolol—Diarrhoea—Mometasone—atopic dermatitis	0.00103	0.00368	CcSEcCtD
Penbutolol—Pain—Tacrolimus—atopic dermatitis	0.00103	0.00366	CcSEcCtD
Penbutolol—Bradycardia—Triamcinolone—atopic dermatitis	0.00101	0.0036	CcSEcCtD
Penbutolol—Bradycardia—Methylprednisolone—atopic dermatitis	0.00101	0.0036	CcSEcCtD
Penbutolol—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000991	0.00353	CcSEcCtD
Penbutolol—Body temperature increased—Tacrolimus—atopic dermatitis	0.000951	0.00339	CcSEcCtD
Penbutolol—Headache—Mometasone—atopic dermatitis	0.000946	0.00337	CcSEcCtD
Penbutolol—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00094	0.00335	CcSEcCtD
Penbutolol—Bradycardia—Betamethasone—atopic dermatitis	0.000918	0.00327	CcSEcCtD
Penbutolol—Bradycardia—Dexamethasone—atopic dermatitis	0.000918	0.00327	CcSEcCtD
Penbutolol—Erectile dysfunction—Prednisone—atopic dermatitis	0.000904	0.00322	CcSEcCtD
Penbutolol—Nausea—Mometasone—atopic dermatitis	0.000897	0.0032	CcSEcCtD
Penbutolol—Depression—Prednisone—atopic dermatitis	0.000873	0.00311	CcSEcCtD
Penbutolol—Asthenia—Tacrolimus—atopic dermatitis	0.000863	0.00307	CcSEcCtD
Penbutolol—Diarrhoea—Tacrolimus—atopic dermatitis	0.000823	0.00293	CcSEcCtD
Penbutolol—Bradycardia—Prednisone—atopic dermatitis	0.0008	0.00285	CcSEcCtD
Penbutolol—Alopecia—Dexamethasone—atopic dermatitis	0.000797	0.00284	CcSEcCtD
Penbutolol—Alopecia—Betamethasone—atopic dermatitis	0.000797	0.00284	CcSEcCtD
Penbutolol—Dizziness—Tacrolimus—atopic dermatitis	0.000795	0.00283	CcSEcCtD
Penbutolol—Cough—Triamcinolone—atopic dermatitis	0.000755	0.00269	CcSEcCtD
Penbutolol—Headache—Tacrolimus—atopic dermatitis	0.000753	0.00268	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000742	0.00264	CcSEcCtD
Penbutolol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000725	0.00258	CcSEcCtD
Penbutolol—Nausea—Tacrolimus—atopic dermatitis	0.000714	0.00254	CcSEcCtD
Penbutolol—Insomnia—Prednisolone—atopic dermatitis	0.000695	0.00247	CcSEcCtD
Penbutolol—Alopecia—Prednisone—atopic dermatitis	0.000694	0.00247	CcSEcCtD
Penbutolol—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000683	0.00243	CcSEcCtD
Penbutolol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000681	0.00243	CcSEcCtD
Penbutolol—Insomnia—Hydrocortisone—atopic dermatitis	0.000678	0.00242	CcSEcCtD
Penbutolol—Dyspepsia—Hydrocortisone—atopic dermatitis	0.00066	0.00235	CcSEcCtD
Penbutolol—Pain—Prednisolone—atopic dermatitis	0.000657	0.00234	CcSEcCtD
Penbutolol—Fatigue—Hydrocortisone—atopic dermatitis	0.000647	0.0023	CcSEcCtD
Penbutolol—Pain—Hydrocortisone—atopic dermatitis	0.000641	0.00228	CcSEcCtD
Penbutolol—Insomnia—Triamcinolone—atopic dermatitis	0.000639	0.00228	CcSEcCtD
Penbutolol—Insomnia—Methylprednisolone—atopic dermatitis	0.000637	0.00227	CcSEcCtD
Penbutolol—Dyspnoea—Triamcinolone—atopic dermatitis	0.00063	0.00224	CcSEcCtD
Penbutolol—Dyspepsia—Triamcinolone—atopic dermatitis	0.000622	0.00221	CcSEcCtD
Penbutolol—Dyspepsia—Methylprednisolone—atopic dermatitis	0.00062	0.00221	CcSEcCtD
Penbutolol—Hyperhidrosis—Betamethasone—atopic dermatitis	0.00062	0.00221	CcSEcCtD
Penbutolol—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.00062	0.00221	CcSEcCtD
Penbutolol—Fatigue—Triamcinolone—atopic dermatitis	0.000609	0.00217	CcSEcCtD
Penbutolol—Fatigue—Methylprednisolone—atopic dermatitis	0.000608	0.00216	CcSEcCtD
Penbutolol—Pain—Triamcinolone—atopic dermatitis	0.000604	0.00215	CcSEcCtD
Penbutolol—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000593	0.00211	CcSEcCtD
Penbutolol—Insomnia—Betamethasone—atopic dermatitis	0.00058	0.00206	CcSEcCtD
Penbutolol—Insomnia—Dexamethasone—atopic dermatitis	0.00058	0.00206	CcSEcCtD
Penbutolol—Dyspepsia—Betamethasone—atopic dermatitis	0.000564	0.00201	CcSEcCtD
Penbutolol—Dyspepsia—Dexamethasone—atopic dermatitis	0.000564	0.00201	CcSEcCtD
Penbutolol—Body temperature increased—Triamcinolone—atopic dermatitis	0.000558	0.00199	CcSEcCtD
Penbutolol—Fatigue—Betamethasone—atopic dermatitis	0.000553	0.00197	CcSEcCtD
Penbutolol—Fatigue—Dexamethasone—atopic dermatitis	0.000553	0.00197	CcSEcCtD
Penbutolol—Pain—Betamethasone—atopic dermatitis	0.000548	0.00195	CcSEcCtD
Penbutolol—Pain—Dexamethasone—atopic dermatitis	0.000548	0.00195	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisone—atopic dermatitis	0.00054	0.00192	CcSEcCtD
Penbutolol—Asthenia—Hydrocortisone—atopic dermatitis	0.000538	0.00192	CcSEcCtD
Penbutolol—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000513	0.00183	CcSEcCtD
Penbutolol—Dizziness—Prednisolone—atopic dermatitis	0.000508	0.00181	CcSEcCtD
Penbutolol—Asthenia—Triamcinolone—atopic dermatitis	0.000507	0.0018	CcSEcCtD
Penbutolol—Body temperature increased—Dexamethasone—atopic dermatitis	0.000507	0.0018	CcSEcCtD
Penbutolol—Body temperature increased—Betamethasone—atopic dermatitis	0.000507	0.0018	CcSEcCtD
Penbutolol—Asthenia—Methylprednisolone—atopic dermatitis	0.000506	0.0018	CcSEcCtD
Penbutolol—Insomnia—Prednisone—atopic dermatitis	0.000505	0.0018	CcSEcCtD
Penbutolol—Dizziness—Hydrocortisone—atopic dermatitis	0.000496	0.00177	CcSEcCtD
Penbutolol—Dyspepsia—Prednisone—atopic dermatitis	0.000491	0.00175	CcSEcCtD
Penbutolol—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000482	0.00172	CcSEcCtD
Penbutolol—Fatigue—Prednisone—atopic dermatitis	0.000481	0.00171	CcSEcCtD
Penbutolol—Headache—Prednisolone—atopic dermatitis	0.000481	0.00171	CcSEcCtD
Penbutolol—Headache—Hydrocortisone—atopic dermatitis	0.00047	0.00167	CcSEcCtD
Penbutolol—Dizziness—Triamcinolone—atopic dermatitis	0.000467	0.00166	CcSEcCtD
Penbutolol—Dizziness—Methylprednisolone—atopic dermatitis	0.000466	0.00166	CcSEcCtD
Penbutolol—Asthenia—Betamethasone—atopic dermatitis	0.00046	0.00164	CcSEcCtD
Penbutolol—Asthenia—Dexamethasone—atopic dermatitis	0.00046	0.00164	CcSEcCtD
Penbutolol—Nausea—Prednisolone—atopic dermatitis	0.000456	0.00162	CcSEcCtD
Penbutolol—Nausea—Hydrocortisone—atopic dermatitis	0.000446	0.00159	CcSEcCtD
Penbutolol—Headache—Triamcinolone—atopic dermatitis	0.000442	0.00158	CcSEcCtD
Penbutolol—Headache—Methylprednisolone—atopic dermatitis	0.000441	0.00157	CcSEcCtD
Penbutolol—Body temperature increased—Prednisone—atopic dermatitis	0.000441	0.00157	CcSEcCtD
Penbutolol—Diarrhoea—Dexamethasone—atopic dermatitis	0.000438	0.00156	CcSEcCtD
Penbutolol—Diarrhoea—Betamethasone—atopic dermatitis	0.000438	0.00156	CcSEcCtD
Penbutolol—Dizziness—Dexamethasone—atopic dermatitis	0.000424	0.00151	CcSEcCtD
Penbutolol—Dizziness—Betamethasone—atopic dermatitis	0.000424	0.00151	CcSEcCtD
Penbutolol—Nausea—Triamcinolone—atopic dermatitis	0.00042	0.00149	CcSEcCtD
Penbutolol—Nausea—Methylprednisolone—atopic dermatitis	0.000419	0.00149	CcSEcCtD
Penbutolol—Headache—Dexamethasone—atopic dermatitis	0.000401	0.00143	CcSEcCtD
Penbutolol—Headache—Betamethasone—atopic dermatitis	0.000401	0.00143	CcSEcCtD
Penbutolol—Asthenia—Prednisone—atopic dermatitis	0.0004	0.00143	CcSEcCtD
Penbutolol—Diarrhoea—Prednisone—atopic dermatitis	0.000382	0.00136	CcSEcCtD
Penbutolol—Nausea—Dexamethasone—atopic dermatitis	0.000381	0.00136	CcSEcCtD
Penbutolol—Nausea—Betamethasone—atopic dermatitis	0.000381	0.00136	CcSEcCtD
Penbutolol—Dizziness—Prednisone—atopic dermatitis	0.000369	0.00131	CcSEcCtD
Penbutolol—Headache—Prednisone—atopic dermatitis	0.00035	0.00125	CcSEcCtD
Penbutolol—Nausea—Prednisone—atopic dermatitis	0.000332	0.00118	CcSEcCtD
Penbutolol—HTR1B—GPCR ligand binding—TAC1—atopic dermatitis	7.58e-05	0.00446	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—NPS—atopic dermatitis	7.58e-05	0.00446	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CXCL10—atopic dermatitis	7.56e-05	0.00445	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	7.44e-05	0.00438	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CXCR3—atopic dermatitis	7.43e-05	0.00437	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCL27—atopic dermatitis	7.41e-05	0.00436	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.14e-05	0.0042	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.79e-05	0.004	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CCR3—atopic dermatitis	6.77e-05	0.00399	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCL17—atopic dermatitis	6.64e-05	0.00391	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CCR3—atopic dermatitis	6.63e-05	0.0039	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL22—atopic dermatitis	6.62e-05	0.00389	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CCL5—atopic dermatitis	6.51e-05	0.00383	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCL27—atopic dermatitis	6.49e-05	0.00382	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CCR3—atopic dermatitis	6.48e-05	0.00381	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL22—atopic dermatitis	6.47e-05	0.00381	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCL27—atopic dermatitis	6.35e-05	0.00374	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL22—atopic dermatitis	6.33e-05	0.00372	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	6.28e-05	0.0037	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCL27—atopic dermatitis	6.21e-05	0.00366	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	6.15e-05	0.00362	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.12e-05	0.0036	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—TAC1—atopic dermatitis	6.04e-05	0.00355	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—NPS—atopic dermatitis	6.04e-05	0.00355	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	6.01e-05	0.00354	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CXCL10—atopic dermatitis	6.01e-05	0.00354	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CXCR3—atopic dermatitis	5.92e-05	0.00348	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—TAC1—atopic dermatitis	5.91e-05	0.00348	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—NPS—atopic dermatitis	5.91e-05	0.00348	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL27—atopic dermatitis	5.9e-05	0.00347	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CCR5—atopic dermatitis	5.86e-05	0.00345	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCR3—atopic dermatitis	5.79e-05	0.00341	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—TAC1—atopic dermatitis	5.77e-05	0.0034	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—NPS—atopic dermatitis	5.77e-05	0.0034	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL27—atopic dermatitis	5.77e-05	0.0034	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	5.69e-05	0.00335	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCR3—atopic dermatitis	5.66e-05	0.00333	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL27—atopic dermatitis	5.64e-05	0.00332	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	5.56e-05	0.00327	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	5.44e-05	0.0032	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	5.41e-05	0.00318	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCL11—atopic dermatitis	5.35e-05	0.00315	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	5.29e-05	0.00311	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL17—atopic dermatitis	5.29e-05	0.00311	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FCER2—atopic dermatitis	5.28e-05	0.00311	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL17—atopic dermatitis	5.17e-05	0.00305	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	5.17e-05	0.00304	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CCL5—atopic dermatitis	5.17e-05	0.00304	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL17—atopic dermatitis	5.06e-05	0.00298	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	4.92e-05	0.0029	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL22—atopic dermatitis	4.91e-05	0.00289	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.87e-05	0.00287	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CCR3—atopic dermatitis	4.81e-05	0.00283	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CXCL10—atopic dermatitis	4.79e-05	0.00282	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.77e-05	0.00281	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	4.72e-05	0.00278	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCL10—atopic dermatitis	4.68e-05	0.00275	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.66e-05	0.00274	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CCR5—atopic dermatitis	4.66e-05	0.00274	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.65e-05	0.00274	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCL10—atopic dermatitis	4.58e-05	0.00269	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL27—atopic dermatitis	4.37e-05	0.00257	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCR3—atopic dermatitis	4.36e-05	0.00257	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—TAC1—atopic dermatitis	4.28e-05	0.00252	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—NPS—atopic dermatitis	4.28e-05	0.00252	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL11—atopic dermatitis	4.26e-05	0.00251	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FCER2—atopic dermatitis	4.2e-05	0.00247	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	4.2e-05	0.00247	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL11—atopic dermatitis	4.17e-05	0.00245	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CCL5—atopic dermatitis	4.12e-05	0.00242	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FCER2—atopic dermatitis	4.11e-05	0.00242	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL11—atopic dermatitis	4.08e-05	0.0024	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CCL5—atopic dermatitis	4.03e-05	0.00237	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FCER2—atopic dermatitis	4.02e-05	0.00237	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—IL5—atopic dermatitis	3.98e-05	0.00234	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CCL5—atopic dermatitis	3.94e-05	0.00232	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL17—atopic dermatitis	3.92e-05	0.00231	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL22—atopic dermatitis	3.91e-05	0.0023	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—TAC1—atopic dermatitis	3.89e-05	0.00229	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—NPS—atopic dermatitis	3.89e-05	0.00229	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCR3—atopic dermatitis	3.83e-05	0.00225	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL22—atopic dermatitis	3.82e-05	0.00225	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCR3—atopic dermatitis	3.81e-05	0.00224	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCR3—atopic dermatitis	3.74e-05	0.0022	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	3.74e-05	0.0022	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CCR5—atopic dermatitis	3.71e-05	0.00218	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.7e-05	0.00218	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	3.66e-05	0.00215	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CCR5—atopic dermatitis	3.63e-05	0.00214	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	3.62e-05	0.00213	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	3.55e-05	0.00209	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.54e-05	0.00209	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	3.5e-05	0.00206	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL27—atopic dermatitis	3.48e-05	0.00205	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCR3—atopic dermatitis	3.48e-05	0.00205	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	3.42e-05	0.00202	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—TAC1—atopic dermatitis	3.41e-05	0.00201	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—NPS—atopic dermatitis	3.41e-05	0.00201	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL27—atopic dermatitis	3.41e-05	0.00201	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCR3—atopic dermatitis	3.4e-05	0.002	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.4e-05	0.002	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCR3—atopic dermatitis	3.35e-05	0.00197	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—NPS—atopic dermatitis	3.34e-05	0.00196	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—TAC1—atopic dermatitis	3.34e-05	0.00196	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	3.33e-05	0.00196	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	3.32e-05	0.00196	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCR3—atopic dermatitis	3.27e-05	0.00193	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	3.26e-05	0.00192	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	3.26e-05	0.00192	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.2e-05	0.00188	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—IL5—atopic dermatitis	3.17e-05	0.00187	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	3.16e-05	0.00186	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	3.16e-05	0.00186	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL17—atopic dermatitis	3.12e-05	0.00184	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL5—atopic dermatitis	3.1e-05	0.00183	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—NPS—atopic dermatitis	3.1e-05	0.00182	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—TAC1—atopic dermatitis	3.1e-05	0.00182	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	3.08e-05	0.00181	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL17—atopic dermatitis	3.06e-05	0.0018	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCR3—atopic dermatitis	3.04e-05	0.00179	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	3.03e-05	0.00179	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—NPS—atopic dermatitis	3.03e-05	0.00178	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—TAC1—atopic dermatitis	3.03e-05	0.00178	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	2.99e-05	0.00176	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	2.97e-05	0.00175	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCR3—atopic dermatitis	2.97e-05	0.00175	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	2.96e-05	0.00174	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	2.96e-05	0.00174	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.95e-05	0.00173	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	2.92e-05	0.00172	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	2.91e-05	0.00171	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.88e-05	0.0017	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL5—atopic dermatitis	2.88e-05	0.00169	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.82e-05	0.00166	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL5—atopic dermatitis	2.82e-05	0.00166	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	2.82e-05	0.00166	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KIF3A—atopic dermatitis	2.79e-05	0.00164	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.76e-05	0.00163	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	2.75e-05	0.00162	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KIF3A—atopic dermatitis	2.72e-05	0.0016	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL10—atopic dermatitis	2.7e-05	0.00159	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	2.66e-05	0.00157	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	2.65e-05	0.00156	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL10—atopic dermatitis	2.65e-05	0.00156	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	2.63e-05	0.00155	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.59e-05	0.00152	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	2.58e-05	0.00152	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CMA1—atopic dermatitis	2.52e-05	0.00148	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL11—atopic dermatitis	2.52e-05	0.00148	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CMA1—atopic dermatitis	2.46e-05	0.00145	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL11—atopic dermatitis	2.46e-05	0.00145	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	2.46e-05	0.00145	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	2.41e-05	0.00142	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	2.41e-05	0.00142	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	2.4e-05	0.00141	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	2.39e-05	0.00141	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	2.37e-05	0.00139	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	2.35e-05	0.00138	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	2.33e-05	0.00137	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	2.32e-05	0.00136	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NPS—atopic dermatitis	2.3e-05	0.00135	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	2.3e-05	0.00135	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	2.28e-05	0.00134	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	2.27e-05	0.00133	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	2.25e-05	0.00133	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	2.24e-05	0.00132	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	2.23e-05	0.00131	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	2.19e-05	0.00129	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	2.15e-05	0.00126	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL5—atopic dermatitis	2.14e-05	0.00126	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	2.11e-05	0.00124	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	2.1e-05	0.00123	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	2.07e-05	0.00122	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	2.05e-05	0.00121	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	2.05e-05	0.00121	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	2.02e-05	0.00119	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	2.01e-05	0.00118	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	2.01e-05	0.00118	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	1.96e-05	0.00116	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	1.9e-05	0.00112	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	1.86e-05	0.0011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NPS—atopic dermatitis	1.83e-05	0.00108	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	1.83e-05	0.00108	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	1.82e-05	0.00107	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	1.82e-05	0.00107	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	1.79e-05	0.00106	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	1.79e-05	0.00105	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NPS—atopic dermatitis	1.79e-05	0.00105	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	1.76e-05	0.00103	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NPS—atopic dermatitis	1.75e-05	0.00103	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	1.75e-05	0.00103	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.72e-05	0.00101	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL5—atopic dermatitis	1.7e-05	0.001	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL5—atopic dermatitis	1.66e-05	0.000979	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.63e-05	0.000958	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.59e-05	0.000937	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.57e-05	0.000923	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.52e-05	0.000895	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.45e-05	0.000855	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	1.45e-05	0.000854	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.45e-05	0.000851	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	1.42e-05	0.000835	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.41e-05	0.000831	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.39e-05	0.000817	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.38e-05	0.000813	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.27e-05	0.000746	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	1.25e-05	0.000735	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.24e-05	0.00073	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	1.22e-05	0.000719	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.21e-05	0.000714	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	1.21e-05	0.000713	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.2e-05	0.000705	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	1.19e-05	0.000703	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	1.19e-05	0.000698	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	1.16e-05	0.000682	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NGF—atopic dermatitis	1.16e-05	0.000681	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	1.15e-05	0.000678	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NGF—atopic dermatitis	1.13e-05	0.000666	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	1.13e-05	0.000663	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	1.13e-05	0.000662	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NGF—atopic dermatitis	1.11e-05	0.000651	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.1e-05	0.000648	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	1.1e-05	0.000648	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	1.1e-05	0.000648	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	1.08e-05	0.000633	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	1.08e-05	0.000633	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	1.05e-05	0.000619	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	9.54e-06	0.000561	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	9.33e-06	0.000549	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	9.12e-06	0.000537	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	8.54e-06	0.000503	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL2—atopic dermatitis	8.16e-06	0.00048	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	8.12e-06	0.000478	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	7.51e-06	0.000442	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	6.8e-06	0.0004	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	6.65e-06	0.000392	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	6.51e-06	0.000383	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2—atopic dermatitis	6.5e-06	0.000383	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	6.47e-06	0.000381	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2—atopic dermatitis	6.36e-06	0.000374	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	6.33e-06	0.000372	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2—atopic dermatitis	6.22e-06	0.000366	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	6.19e-06	0.000364	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	5.98e-06	0.000352	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	5.85e-06	0.000344	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	5.72e-06	0.000337	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—atopic dermatitis	4.8e-06	0.000282	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—atopic dermatitis	3.82e-06	0.000225	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—atopic dermatitis	3.74e-06	0.00022	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—atopic dermatitis	3.65e-06	0.000215	CbGpPWpGaD
